The Operating Theatre Journal November 2020

More documents

Recommendations

Info

JUNE Medical launchesmale surgical retractor kitJUNE MEDICAL is expanding its comprehensive portfolio of medicaldevices with the upcoming launch of its new pre-packed retractor kitsespecially for male procedures. Based on the company’s award-winningGalaxy II retractor, the Galaxy II Male kit brings the same level ofinnovation to male surgeries.The Galaxy II Male kit is set to revolutionise male procedures bydramatically improving visualisation during surgery. This straightforwardand easy to use kit is suitable for a wide range of procedures requiringoptimal control over the surgical site, such as scrotal and associatedsurgeries, as well as prosthetic testicle implantations. The kit featuresa number of different accessories and a novel hammock elevation strapto manoeuvre the male anatomy, allowing the penis to be held securelywithout requiring hooks through the skin, improving patient comfort.The kit also benefits from all of the characteristics that have madethe Galaxy II system so popular. The retractor’s unique, designprotected cam locks allow simple single-handed adjustment for rapidre-positioning, while the slots on the retractor ring easily secure thestays in place. Together with a range of stay hooks designed to enablehigh tension without the risk of tissue tearing, this system provides aninnovative, cost-effective and convenient solution for a wide range ofsurgical procedures.Angela Spang, CEO of JUNE Medical, commented: “The Galaxy II freesup the hands of assistants and nurses that often have to hold theretractor, sometimes for long periods of time. This improves efficiencyand reduces the numbers of people needed in the operating room,which is especially useful during the COVID-19 pandemic to help reduceinfection risk.”Visit the JUNE Medical website www.galaxyretractor.comto learn more.When responding to articles please quote ‘OTJ’One of world’s largest spine study highlightsrisk factors of prolapsed disc post-surgeryData from one of the world’s largest spine study, which analysed thereoccurrence and risk factors of prolapsed disc post-surgery, has beenpresented at this year’s EUROSPINE conference by London NorwichSpine Clinic.Collected over a 10-year period, the study reviewed 888 lumbardiscectomy patients who all had a minimum of two years follow-up.The results revealed that the female sex, smoking, and having a higherpre-operation disability were all factors for reherniation.The research was carried out bySpinal Consultant Mr Am Rai andhis colleagues from the Departmentof Orthopaedics and Spinal Surgeryat the Spire Norwich Hospital andNorfolk and Norwich UniversityHospital.Surgical discectomy is aneffective treatment for lumbarintervertebral disc herniation butdespite developments in technique,the incidence of reoperation isestimated to be between 13% to25%. Until now robust predictivemetrics and risk factors associatedwith recurrent lumbar discherniation haven’t been clearlydefined.The independent study looked at patient demographics and patientreportedoutcome measures including back and leg pain. Postoperativedata was also collected from clinical notes and MRI database and theteam checked against all imaging providers in the region. Diagnosis wasconfirmed clinically or by operative findingsMr Rai explains: “The rate of reherniation after lumbar discectomyvaries widely and the role of risk factors has not been fully established.Equally, among clinicians, the subsequent treatment option in themanagement of symptomatic recurrent lumbar disc herniation remainsunclear.“The aim of the study was therefore to identify the true incidenceand the associated risk factors. It is the largest one of its kind andthe findings are important for healthcare practitioners globally whendeveloping management strategies.”The London Norwich Spine Clinic was founded by Mr Rai in 2003 to givepatients with spinal conditions access to the best surgical care.Headquartered in Norwich, and with state-of-the-art facilities inLondon, the clinic specialises in treating a wide range of problems,including disc herniations in the neck and lower back, spinaldeformities such as scoliosis and kyphosis in adults and children, plustrauma, infections and tumours. With access to world-class diagnosticequipment, the specialist clinic offers both conservative and surgicaltechniques, providing innovative solutions and personalised care forpatients from across the UK and abroad.Mr Rai was elected President of the British Association of SpinalSurgeons by his surgical peers and has been on the BASS ExecutiveCommittee for 6 years. He has also published on national best practicesurgical guidelines, helped develop the British Spinal Registry (over140,000 patients), and been involved in National Institute for Healthand Care Excellence (NICE) guidelines and government-led regionalvariation in surgical practice across England.Due to COVID-19 restrictions, the research was presented virtually atEUROSPINE – an international conference hosted by the Spine Society ofEurope. The event shares knowledge and ideas in the field of research,prevention and treatment of spine diseases and related problems,and coordinates efforts undertaken in European countries for furtherdevelopment in this field.About London Norwich Spine https://londonnorwichspine.co.uk/When responding to articles please quote ‘OTJ’www.Operating peratingTheatre heatreJobs.comA one-stop resource for ALL your theatre related Career opportunitiesView the latest vacancies online !10 THE OPERATING THEATRE JOURNAL www.otjonline.com
Mölnlycke Procedure TraysSave 40% of your preparation time andreduce costs with customised procedure trays.Contact us today to find out morewww.molnlycke.co.uk Telephone: 0800 917 4918References: Greiling, M. A multinational case study to evaluate and quantify time-saving by using custom procedure trays for operating room efficiency.Data presented at the 23rd Congress of the European Association of Hospital Managers, Zurich, Switzerland, September 2010 (poster).Mölnlycke Health Care Ltd, Unity House, Medlock Street,Oldham, OL1 3HS UK. Tel. 0800 731 1876 Email: info.uk@molnlycke.comThe Mölnlycke trademarks, names and logos are registered globally to one or more of the Mölnlycke Health Care group ofcompanies. © 2020 Mölnlycke Health Care. All rights reserved. UKSU0136.Keeping eyes on the patient: Mindray confirms new anaesthesiamachines will launch in the UKMindray has announced it will be launching its new A8 and A9anaesthesia machines in the UK market.The two systems are the medical device manufacturer’s most advancedanaesthesia products to date, offering market-leading connectivityoptions and innovative patient safety features.Both the A8 and A9 are the first devices in the industry to have integratedhigh flow nasal cannula (HFNC) technology within the anaesthesiamachine.The feature helps extend the window of therapeutic action foranaesthetists by prolonging safe apnoeic oxygenation levels, allowing upto 30 minutes of safe oxygenated apnoea time. Studies by the BritishJournal of Anaesthesia found that HFNC can more than double theaverage duration of aponea before desaturation.2,3Data from a wide range of external monitoring modules such as bispectralindex, neuromuscular transmission and intravenous imaging, can beseamlessly integrated and displayed by the new devices without any extramonitoring screens.Enabling anaesthetists to collect more data at a glance, the modulardesign also fulfils the need for fewer devices in theatre, allowinganaesthetists to utilise a larger workspace and spend more time closelyobserving their patients.A study in the Anesthesia & Analgesia journal found that anaesthesiologistslook at their monitor in one to two second glances, therefore displaysshould be developed to optimise this short window of information.1In order to optimise gas usage and quickly provide a balanced responseto changes in patient status without user intervention, the A9 usesAutomatic Controlled Anaesthesia (ACA). Through its precision electronicvaporiser and ACA platform, the A9 adjusts fresh gas and vaporiseroutput to hit patient targets using both end-tidal and inspiratory oxygenmeasurements.The new systems also utilise a suite of gas reduction tools to minimisethe environmental and economic impact of surgery by preventing leakageand managing usage, improving patient safety in the process. Both theA8 and A9 can offer suggestions on optimal fresh gas flow, provide realtimeusage metrics, pause to prevent leakage, and indicate flow rateabnormalities.Mindray A9 (in use)Mindray’s innovative volume exchanger design allows the two devices todeliver ICU-level ventilation, offering greater precision and protection forall patients during ventilation. The system has no moving parts and issupported by a range of protective ventilation tools, offering reliable andsafe ventilation to reduce the occurrence of post-operative complications.The devices demonstrate Mindray’s commitment to improving connectivityby easily connecting to existing devices and patient data managementsystems, from central workstations to bedside monitors. Both systems canalso be configured for up to 10 individual patient profiles, an industry-first.This interconnected approach provides greater data visibility throughoutthe patient journey, minimising risks and improving patient care.For more information, please register for the online product launchhttps://www.mindray-virtual.com/loginReferences:1. Ford S, et al. At-a-Glance Monitoring: Covert Observations of Anesthesiologists in theOperating Room, Anesthesia & Analgesia 2010; 111: 653 – 658.2. Gustafsson I, et al. Apnoeic oxygenation in adults under general anaesthesia usingTransnasal Humidified Rapid-Insufflation Ventilatory Exchange, British Journal ofAnaesthesia 2017; 118: 610–177.3. Frerk C, Mitchell VS, McNarry AF, et al. Difficult Airway Society 2015 guidelines formanagement of unanticipated difficult intubation in adults. British Journal of Anaesthesia2015; 115: 827–48.When responding to articles please quote ‘OTJ’Find out more 02921 680068 • e-mail admin@lawrand.com Issue 362 November 2020 11
Page 1 and 2: £2.00November 2020 Issue No. 362 I
Page 3 and 4: November 2020 Issue No. 362 ISSN 17
Page 5 and 6: Introducing the newCS Spine Frame+
Page 7 and 8: Covid-19 What have we learned about
Page 9: Trying to catch up withday-to-day d
Page 13 and 14: http://bit.ly/OTJtheatreSummitGetin
Page 15 and 16: Lithotomy Stirrups from Melyd Surgi
Page 17 and 18: Vygon signs exclusive agreement wit
Page 19 and 20: Hospital InnovationsStay Safe PPE R
Page 21 and 22: nightentify’s newwill aationsbrin
Page 23 and 24: Discovering the many more pages ava
Page 25 and 26: Their portfolio comprises a range o
Page 27 and 28: MMI SpA Launches Breakthrough Techn
Page 29 and 30: Reduced manual handlingfor transpor

The Operating Theatre Journal November 2020

Create successful ePaper yourself

Delete template?

Save as template?